In this case, we examined immunoreactivity of neoplastic cells for S100 to differentiate from schwannoma, CD34 to differentiate from solitary fibrous tumour, and HMB45 to differentiate angiomyolipoma. The gene discussed is PMEL; the disease is schwannoma.